540788 — Aspira Pathlab & Diagnostics Balance Sheet
0.000.00%
- IN₹699.82m
- IN₹700.54m
- IN₹132.05m
- 79
- 11
- 81
- 62
Annual balance sheet for Aspira Pathlab & Diagnostics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 11 | 11.9 | 16.4 | 23.5 | 13.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 16.8 | 22.6 | 50 | 29.5 | 24.1 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 32.9 | 38.8 | 71.4 | 58.6 | 43.6 |
Net Property, Plant And Equipment | 60.4 | 49.6 | 68.2 | 53.1 | 41.2 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 143 | 118 | 181 | 173 | 147 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 51.2 | 20.1 | 17.9 | 15.8 | 20.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 105 | 34.6 | 53.5 | 45.9 | 45.7 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 38 | 83.1 | 128 | 128 | 101 |
Total Liabilities & Shareholders' Equity | 143 | 118 | 181 | 173 | 147 |
Total Common Shares Outstanding |